Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Shares Outstanding (Weighted Average) (2018 - 2025)

Historic Shares Outstanding (Weighted Average) for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $984927.0.

  • Dna X's Shares Outstanding (Weighted Average) rose 26561.65% to $984927.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $984927.0, marking a year-over-year increase of 26561.65%. This contributed to the annual value of $4.7 million for FY2024, which is 1003.91% up from last year.
  • Per Dna X's latest filing, its Shares Outstanding (Weighted Average) stood at $984927.0 for Q3 2025, which was up 26561.65% from $9.5 million recorded in Q2 2025.
  • In the past 5 years, Dna X's Shares Outstanding (Weighted Average) ranged from a high of $40.9 million in Q1 2023 and a low of $269388.0 during Q3 2024
  • Over the past 5 years, Dna X's median Shares Outstanding (Weighted Average) value was $6.6 million (recorded in 2021), while the average stood at $11.5 million.
  • In the last 5 years, Dna X's Shares Outstanding (Weighted Average) surged by 33131.73% in 2022 and then plummeted by 9374.09% in 2024.
  • Dna X's Shares Outstanding (Weighted Average) (Quarter) stood at $9.5 million in 2021, then soared by 205.23% to $28.9 million in 2022, then tumbled by 85.16% to $4.3 million in 2023, then rose by 10.04% to $4.7 million in 2024, then crashed by 79.12% to $984927.0 in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $984927.0 for Q3 2025, versus $9.5 million for Q2 2025 and $5.8 million for Q1 2025.